Vladimir Leonidovich Emanuel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vladimir Leonidovich Emanuel has a total of 297 co-authors. Here are the top co-authors by number of shared publications:
- Sergey Vladimirovich Lapin
First Pavlov State Medical University of St. Petersburg
23 shared publications - Vladimir Dmitrievich Nazarov
First Pavlov State Medical University of St. Petersburg
15 shared publications - Aleksandra V. Mazing
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
11 shared publications - Margarita Yu. Pervakova
НИИ детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России, ул. Льва Толстого, д. 6/8, Санкт-Петербург, Российская Федерация, 197022
7 shared publications - Nikolay A. Verlov
Petersburg Nuclear Physics Institute named by B.P.Konstantinov of National Research Centre «Kurchatov Institute
7 shared publications - Maxim Sergeevich Vonsky
D. I. Mendeleyev Institute for Metrology
6 shared publications
Latest Publications
- 15 November 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (4) , 851-866
Cytokine levels in patients with various MEFV genotypes
Familial Mediterranean fever (FMF) is a monogenic autosomal recessive autoinflammatory disease caused by MEFV gene pathogenic variants. Heterozygosity for the MEFV gene remains a clinically challenging issue, since homozygous mutations are generally required for disease manifestation. Individuals with one pathogenic variant are only mutation carriers. However, in many cases, clinical signs of FMF are exhibited in heterozygous carriers of MEFV variants. Our aim was to study the cytokine profile in patients with detected MEFV variants, taking into account molecular genetic features such as zygosity and aggressiveness of pathogenic variants. The study included 275 patients referred for MEFV genetic testing. Genomic DNA and EDTA-plasma were obtained from all subjects. Sanger sequencing of exons 2, 3, 5, and 10 of the MEFV gene was performed. Plasma levels of CRP, IL-1b, IL-6, IL-8, and IL-18 were measured by ELISA technique. A control group comprised 24 healthy donors from the laboratory biobank. Statistical analysis was carried out using GraphPad Prism 8. As based on genotyping data, 275 samples were divided into groups: wild-type genotype – WT (n = 60); FMF group included homozygous (n = 28), compound heterozygous (n = 71), and heterozygous (n = 86) carriers with combinations of pathogenic and unknown significance variants (VUS) (n = 15). For 15 samples of only VUS carriers, the cytokine levels were not measured. ELISA testing of cytokines has shown an increase of CRP, IL-1b, IL-6 and IL-18 levels in FMF compared to healthy donors (p < 0.0001). An increase of IL-6 (p < 0.05) and IL-18 levels (p < 0.0001) was found in FMF compared to the wild-type (WT) group. No differences were shown for IL-8 level between FMF, WT and healthy donors. Increased levels of CRP (p < 0.01) and IL-18 (p < 0.0001) were shown in the subgroups with aggressive homozygous variants compared to low-aggressive ones. Increased IL-18 level were observed in aggressive heterozygous cases compared to low-aggressive ones (p < 0.05). An increased level of IL-1b (p < 0.05) was shown in the subgroup with two aggressive pathogenic variants compared to subgroup with one aggressive and one low-aggressive pathogenic variant. The genotype and aggressiveness of detected variants influence the activity of the inflammatory process in patients with FMF.
- 15 November 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (4) , 851-866
Cytokine levels in patients with various MEFV genotypes
Familial Mediterranean fever (FMF) is a monogenic autosomal recessive autoinflammatory disease caused by MEFV gene pathogenic variants. Heterozygosity for the MEFV gene remains a clinically challenging issue, since homozygous mutations are generally required for disease manifestation. Individuals with one pathogenic variant are only mutation carriers. However, in many cases, clinical signs of FMF are exhibited in heterozygous carriers of MEFV variants. Our aim was to study the cytokine profile in patients with detected MEFV variants, taking into account molecular genetic features such as zygosity and aggressiveness of pathogenic variants. The study included 275 patients referred for MEFV genetic testing. Genomic DNA and EDTA-plasma were obtained from all subjects. Sanger sequencing of exons 2, 3, 5, and 10 of the MEFV gene was performed. Plasma levels of CRP, IL-1b, IL-6, IL-8, and IL-18 were measured by ELISA technique. A control group comprised 24 healthy donors from the laboratory biobank. Statistical analysis was carried out using GraphPad Prism 8. As based on genotyping data, 275 samples were divided into groups: wild-type genotype – WT (n = 60); FMF group included homozygous (n = 28), compound heterozygous (n = 71), and heterozygous (n = 86) carriers with combinations of pathogenic and unknown significance variants (VUS) (n = 15). For 15 samples of only VUS carriers, the cytokine levels were not measured. ELISA testing of cytokines has shown an increase of CRP, IL-1b, IL-6 and IL-18 levels in FMF compared to healthy donors (p < 0.0001). An increase of IL-6 (p < 0.05) and IL-18 levels (p < 0.0001) was found in FMF compared to the wild-type (WT) group. No differences were shown for IL-8 level between FMF, WT and healthy donors. Increased levels of CRP (p < 0.01) and IL-18 (p < 0.0001) were shown in the subgroups with aggressive homozygous variants compared to low-aggressive ones. Increased IL-18 level were observed in aggressive heterozygous cases compared to low-aggressive ones (p < 0.05). An increased level of IL-1b (p < 0.05) was shown in the subgroup with two aggressive pathogenic variants compared to subgroup with one aggressive and one low-aggressive pathogenic variant. The genotype and aggressiveness of detected variants influence the activity of the inflammatory process in patients with FMF.
- 25 September 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (3) , 121-136
A study of urinary colloidal and protein composition during the induction of dose-dependent oxalate urolithiasis in rats
INTRODUCTION . Oxalate urolithiasis is a common disease, but the mechanisms underlying the transition from crystalluria to kidney damage remain poorly understood. Of particular interest is the role of uromodulin (UMOD) in crystal formation under varying degrees of hyperoxaluria. AIM. To study the dynamics of the colloidal and protein composition of urine in a rat model of acute oxalate urolithiasis. MATERIALS AND METHODS. The study was conducted using male Wistar rats. Acute oxalate nephropathy was induced by intraperitoneal administration of sodium oxalate (NaOx): 2,5 mg/100 g (NaOx L group) and 5 mg/100 g (NaOx H group). The control group received 0,9 % NaCl. Measurements performed in dynamics (2-4 hours, 4-8 hours, 24 hours). The colloidal fraction of urine was assessed using nanoparticle tracking analysis (NTA). The concentration of immunoreactive UMOD was measured by ELISA, and total UMOD concentration was determined by ultrafiltration combined with the Bradford method. The glomerular filtration rate (GFR) was measured by FITC-inulin clearance. Histological examination of the kidneys was also performed. RESULTS . In the experimental groups, after 2-4 hours, a moderate increase was observed in the concentration of colloidal particles (230-240 nm) and a significant increase in the total UMOD relative to the control (p 0,05). In the NaOx H group, depletion of the UMOD pool (13,9 μg/mL, p = 0,051) was detected, crystal aggregates (20-45 μm) obstructed the lumen of Henle loop in more than 75 % of tubules, dilation of Bowman’s capsules and a critical decrease in GFR by 57,8 % (p CONCLUSIONS . The outcome of acute oxalate nephropathy is determined by the balance between the degree of hyperoxaluria and the UMOD pool. With moderate hyperoxaluria, the local UMOD pool is sufficient to encapsulate crystals and ensure their safe elimination. Under high oxalate load, the UMOD pool is depleted, crystallization in the unprotected UMOD thin segment of Henle loop leads to obstruction. The observed dose dependence explains the differences in the severity of kidney damage with varying degrees of hyperoxaluria.
- 25 September 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (3) , 121-136
A study of urinary colloidal and protein composition during the induction of dose-dependent oxalate urolithiasis in rats
INTRODUCTION . Oxalate urolithiasis is a common disease, but the mechanisms underlying the transition from crystalluria to kidney damage remain poorly understood. Of particular interest is the role of uromodulin (UMOD) in crystal formation under varying degrees of hyperoxaluria. AIM. To study the dynamics of the colloidal and protein composition of urine in a rat model of acute oxalate urolithiasis. MATERIALS AND METHODS. The study was conducted using male Wistar rats. Acute oxalate nephropathy was induced by intraperitoneal administration of sodium oxalate (NaOx): 2,5 mg/100 g (NaOx L group) and 5 mg/100 g (NaOx H group). The control group received 0,9 % NaCl. Measurements performed in dynamics (2-4 hours, 4-8 hours, 24 hours). The colloidal fraction of urine was assessed using nanoparticle tracking analysis (NTA). The concentration of immunoreactive UMOD was measured by ELISA, and total UMOD concentration was determined by ultrafiltration combined with the Bradford method. The glomerular filtration rate (GFR) was measured by FITC-inulin clearance. Histological examination of the kidneys was also performed. RESULTS . In the experimental groups, after 2-4 hours, a moderate increase was observed in the concentration of colloidal particles (230-240 nm) and a significant increase in the total UMOD relative to the control (p 0,05). In the NaOx H group, depletion of the UMOD pool (13,9 μg/mL, p = 0,051) was detected, crystal aggregates (20-45 μm) obstructed the lumen of Henle loop in more than 75 % of tubules, dilation of Bowman’s capsules and a critical decrease in GFR by 57,8 % (p CONCLUSIONS . The outcome of acute oxalate nephropathy is determined by the balance between the degree of hyperoxaluria and the UMOD pool. With moderate hyperoxaluria, the local UMOD pool is sufficient to encapsulate crystals and ensure their safe elimination. Under high oxalate load, the UMOD pool is depleted, crystallization in the unprotected UMOD thin segment of Henle loop leads to obstruction. The observed dose dependence explains the differences in the severity of kidney damage with varying degrees of hyperoxaluria.
- 26 July 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (2) , 36-48
Virtual nephrobiopsy as a knowledge base from functional-morphological patterns
BACKGROUND. Diagnosis of kidney diseases remains a serious challenge, as in many cases it is based on the examination of a kidney biopsy specimen, since the morphological form of the disease determines the treatment strategy, including the use of aggressive pharmacological agents. Non-invasive determination of the pathogenetic group of nephropathy reduces the risk of drug exposure in cases of treatment without morphological diagnosis. THE AIM. Development of a mathematical apparatus for constructing virtual morphological characteristics of the kidneys based on aggregate data on their functional status. PATIENTS AND METHODS. Artificial intelligence technologies with machine learning based on data from 571 patients with morphological diagnoses. RESULTS. The proposed set of medical informatics methods demonstrates potential for virtual pathomorphological modeling and improving healthcare safety by providing clinical decision support. CONCLUSION. The proposed system can be used as a clinical decision support tool, enabling patient stratification into three pathogenetic groups (glomerular, tubulointerstitial, and vascular) that differ in principles of clinical management and drug therapy. This highlights the potential of medical informatics and machine learning methods for improving the clinical interpretability of nephrobiopsy data.
- 26 July 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (2) , 36-48
Virtual nephrobiopsy as a knowledge base from functional-morphological patterns
BACKGROUND. Diagnosis of kidney diseases remains a serious challenge, as in many cases it is based on the examination of a kidney biopsy specimen, since the morphological form of the disease determines the treatment strategy, including the use of aggressive pharmacological agents. Non-invasive determination of the pathogenetic group of nephropathy reduces the risk of drug exposure in cases of treatment without morphological diagnosis. THE AIM. Development of a mathematical apparatus for constructing virtual morphological characteristics of the kidneys based on aggregate data on their functional status. PATIENTS AND METHODS. Artificial intelligence technologies with machine learning based on data from 571 patients with morphological diagnoses. RESULTS. The proposed set of medical informatics methods demonstrates potential for virtual pathomorphological modeling and improving healthcare safety by providing clinical decision support. CONCLUSION. The proposed system can be used as a clinical decision support tool, enabling patient stratification into three pathogenetic groups (glomerular, tubulointerstitial, and vascular) that differ in principles of clinical management and drug therapy. This highlights the potential of medical informatics and machine learning methods for improving the clinical interpretability of nephrobiopsy data.
- 26 July 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (2) , 96-110
Uromodulin as a kidney protective factor in acute oxalate urolithiasis: a dose-dependent mouse model
INTRODUCTION . Urolithiasis is a common urological pathology with a high recurrence rate. Experimental models on rodents are the main tool for studying the pathogenesis of stone formation and the search for therapeutic targets. THE AIM : To develop models of acute oxalate urolithiasis in ICR mice and evaluate the role of uromodulin (UMO) in protecting the kidneys from crystal-induced damage. MATERIALS AND METHODS. The study was performed on 18 male ICR mice (CD 1). Mice were intraperitoneally injected with sodium oxalate in two doses: 2.5 mg/100 g body weight (NaOx L) and 5 mg/100 g body weight (NaOx H). The biochemical parameters of blood, glomerular filtration rate by FITC inulin clearance, colloidal composition of urine, urinary excretion of UMO and ions, morphology of sediment and internal organs were evaluated in the experiment. RESULTS . A high dose of the pathology inducer caused severe acute nephropathy with pronounced azotemia, decreased GFR, accumulation of large CaOx containing nanoparticles, and deep tubulointerstitial damage. A dose of 2.5 mg/100 g of body weight formed a milder, generally compensated lesion with a transient peak of crystalluria. In this group, the dynamics of urinary UMO excretion and colloidal profile most convincingly demonstrated its nephroprotective and anti-crystallogenic role. CONCLUSIONS. The developed two-dose model of acute Ox urolithiasis in mice allows differentiated study of severe crystal-induced kidney damage (5 mg/100 g) and mechanisms of effective crystal clearance with the participation of UMO (2.5 mg/100 g), which creates the basis for molecular genetic studies on transgenic and knockout lines of mice.
- 26 July 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (2) , 96-110
Uromodulin as a kidney protective factor in acute oxalate urolithiasis: a dose-dependent mouse model
INTRODUCTION . Urolithiasis is a common urological pathology with a high recurrence rate. Experimental models on rodents are the main tool for studying the pathogenesis of stone formation and the search for therapeutic targets. THE AIM : To develop models of acute oxalate urolithiasis in ICR mice and evaluate the role of uromodulin (UMO) in protecting the kidneys from crystal-induced damage. MATERIALS AND METHODS. The study was performed on 18 male ICR mice (CD 1). Mice were intraperitoneally injected with sodium oxalate in two doses: 2.5 mg/100 g body weight (NaOx L) and 5 mg/100 g body weight (NaOx H). The biochemical parameters of blood, glomerular filtration rate by FITC inulin clearance, colloidal composition of urine, urinary excretion of UMO and ions, morphology of sediment and internal organs were evaluated in the experiment. RESULTS . A high dose of the pathology inducer caused severe acute nephropathy with pronounced azotemia, decreased GFR, accumulation of large CaOx containing nanoparticles, and deep tubulointerstitial damage. A dose of 2.5 mg/100 g of body weight formed a milder, generally compensated lesion with a transient peak of crystalluria. In this group, the dynamics of urinary UMO excretion and colloidal profile most convincingly demonstrated its nephroprotective and anti-crystallogenic role. CONCLUSIONS. The developed two-dose model of acute Ox urolithiasis in mice allows differentiated study of severe crystal-induced kidney damage (5 mg/100 g) and mechanisms of effective crystal clearance with the participation of UMO (2.5 mg/100 g), which creates the basis for molecular genetic studies on transgenic and knockout lines of mice.
- Open Access
- 9 June 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 33 (1) , 115-125
Correction of biochemical reference intervals taking into account age characteristics in a multidisciplinary hospital
Коррекция референсных интервалов биохимических показателей с учетом возрастных особенностей в условиях многопрофильного стационара
- 9 June 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 33 (1) , 115-125
Open AccessCorrection of biochemical reference intervals taking into account age characteristics in a multidisciplinary hospital
Коррекция референсных интервалов биохимических показателей с учетом возрастных особенностей в условиях многопрофильного стационара
- 3 June 2026
- Published by Alfmed LLC in Medical alphabet
- No. 7
Sources of variation and establishment of Russian reference intervals for major hormones and tumor markers
Objectives. To study the sources of variation (SV) in reference values (RV) for 22 key immunoassays and to determine reference intervals (RIs), a multicenter study of the Russian population was conducted. Methods. In accordance with the protocol of the Committee on Reference Intervals and Limit Values (C‑RIDL) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), 758 healthy volunteers were included in the study, conducted in St. Petersburg, Moscow, and Yekaterinburg. Five tumor markers and 17 hormones and related analytes were analyzed in serum samples using the UniCel DxI 800 immunoassay analyzer from Beckman Coulter. SVs were analyzed using multiple regression analysis (MRA) and analysis of variance (ANOVA). The primary criterion for separating the study population by sex and age was a standard deviation ratio (SDR) of 0.4. Results. When assessing differences between groups of volunteers participating in the study in different cities, the SDR was less than 0.4. The following secondary exclusion criteria were used: for female sex hormones – contraceptive use (8%); for CA19–9—presumably Lewis negative blood type (10.5% of men and 11.3% of women); for insulin – BMI ≥28 kg/m2 (31%); for thyroid hormones – the presence of thyroid antibodies (10.3% of men and 24.5% of women); for carcinoembryonic antigen (CEA)—smoking (30% of men and 16% of women). For all analytes except CA19–9, CA15–3, thyroid function tests, parathyroid hormone, and insulin, RIs had to be separated by sex. For alpha‑fetoprotein (AFP), CEA, all female sex hormones, follicle‑stimulating hormone (FSH), and progesterone, RIs had to be separated by age for both sexes. Typically, RIs were determined parametrically after Gaussian transformation using a modified Box‑Cox formula. Exceptions were growth hormone, estradiol in postmenopausal women, and progesterone in premenopausal women, which required nonparametric calculation due to bimodal distributions and/or insufficient detection limits. Conclusions. RIs for key hormones and tumor markers specific to the Russian population were determined in accordance with a current international standardized protocol with a thorough examination of the RI for each analyte.
- 3 June 2026
- Published by Alfmed LLC in Medical alphabet
- No. 7
Sources of variation and establishment of Russian reference intervals for major hormones and tumor markers
Objectives. To study the sources of variation (SV) in reference values (RV) for 22 key immunoassays and to determine reference intervals (RIs), a multicenter study of the Russian population was conducted. Methods. In accordance with the protocol of the Committee on Reference Intervals and Limit Values (C‑RIDL) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), 758 healthy volunteers were included in the study, conducted in St. Petersburg, Moscow, and Yekaterinburg. Five tumor markers and 17 hormones and related analytes were analyzed in serum samples using the UniCel DxI 800 immunoassay analyzer from Beckman Coulter. SVs were analyzed using multiple regression analysis (MRA) and analysis of variance (ANOVA). The primary criterion for separating the study population by sex and age was a standard deviation ratio (SDR) of 0.4. Results. When assessing differences between groups of volunteers participating in the study in different cities, the SDR was less than 0.4. The following secondary exclusion criteria were used: for female sex hormones – contraceptive use (8%); for CA19–9—presumably Lewis negative blood type (10.5% of men and 11.3% of women); for insulin – BMI ≥28 kg/m2 (31%); for thyroid hormones – the presence of thyroid antibodies (10.3% of men and 24.5% of women); for carcinoembryonic antigen (CEA)—smoking (30% of men and 16% of women). For all analytes except CA19–9, CA15–3, thyroid function tests, parathyroid hormone, and insulin, RIs had to be separated by sex. For alpha‑fetoprotein (AFP), CEA, all female sex hormones, follicle‑stimulating hormone (FSH), and progesterone, RIs had to be separated by age for both sexes. Typically, RIs were determined parametrically after Gaussian transformation using a modified Box‑Cox formula. Exceptions were growth hormone, estradiol in postmenopausal women, and progesterone in premenopausal women, which required nonparametric calculation due to bimodal distributions and/or insufficient detection limits. Conclusions. RIs for key hormones and tumor markers specific to the Russian population were determined in accordance with a current international standardized protocol with a thorough examination of the RI for each analyte.
- 3 June 2026
- Published by Alfmed LLC in Medical alphabet
- No. 7
Functional and morphological characteristics of renal allograft using artificial intelligence and machine learning technologies in post- transplant risk prediction
Background. Timely clinical decision-making regarding interventional management in transplant recipients to preserve allograft function depends on the accuracy of correlating in vitro biomaterial characteristics with native in vivo intermolecular interactions. Aim. To develop a system for short‑term risk stratification and prediction in kidney transplant recipients based on the analysis of functional and morphological pattern dynamics using medical informatics methods. Materials and methods. The analysis included data from 160 kidney transplant recipients comprising a total of 5,531 observations. Current risk assessment was performed using clinically validated in vitro threshold values reflecting allograft function and systemic inflammatory activity. A time‑series analysis model based on Long Short‑Term Memory (LSTM) recurrent neural network was employed for risk category prediction. Results. The predictive system demonstrated high accuracy in short‑term risk classification (approximately 90%) when at least three consecutive days of dynamic monitoring were available. Risk state formation is determined not by isolated deviations of individual parameters, but by coordinated changes in functional and morphological patterns, primarily the most energy‑intensive cyclic ion transport processes and inflammatory markers. Conclusion. The proposed approach may serve as a clinical decision support tool for timely therapy adjustment and allograft function preservation.
- 3 June 2026
- Published by Alfmed LLC in Medical alphabet
- No. 7
Functional and morphological characteristics of renal allograft using artificial intelligence and machine learning technologies in post- transplant risk prediction
Background. Timely clinical decision-making regarding interventional management in transplant recipients to preserve allograft function depends on the accuracy of correlating in vitro biomaterial characteristics with native in vivo intermolecular interactions. Aim. To develop a system for short‑term risk stratification and prediction in kidney transplant recipients based on the analysis of functional and morphological pattern dynamics using medical informatics methods. Materials and methods. The analysis included data from 160 kidney transplant recipients comprising a total of 5,531 observations. Current risk assessment was performed using clinically validated in vitro threshold values reflecting allograft function and systemic inflammatory activity. A time‑series analysis model based on Long Short‑Term Memory (LSTM) recurrent neural network was employed for risk category prediction. Results. The predictive system demonstrated high accuracy in short‑term risk classification (approximately 90%) when at least three consecutive days of dynamic monitoring were available. Risk state formation is determined not by isolated deviations of individual parameters, but by coordinated changes in functional and morphological patterns, primarily the most energy‑intensive cyclic ion transport processes and inflammatory markers. Conclusion. The proposed approach may serve as a clinical decision support tool for timely therapy adjustment and allograft function preservation.
- 26 January 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 29 (4)
Urolithiasis and the major urinary protein
The pathogenetic approach to metaphylaxis of urolithiasis is a widespread, socially significant healthcare issue due to the increasing incidence and, particularly, its recurrent nature, despite advances in pharmacotherapy and the application of lithotripsy. Pathological crystal genesis is viewed as a consequence of exceeding the solubility threshold of various urinary mineral components on one hand, and as a result of post-translational defects in the main proteome of urine formation – uromodulin (UMOD), which demonstrates a sanogenetic system in healthy individuals for maintaining biophysical homeostasis stability: the colloidal properties of urine. However, in addition to this, UMOD, by binding mannose-dependent pili of infectious agents, blocks bacterial contact with urothelial cells, given that urinary tract infection is a known factor in urolithiasis. By modeling the urine of healthy individuals through co-incubation with E. coli bacteria, a decrease in the concentration of polymerized uromodulin in urine has been demonstrated as a factor increasing the risk of calcium oxalate crystal formation.
- 26 January 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 29 (4)
Urolithiasis and the major urinary protein
The pathogenetic approach to metaphylaxis of urolithiasis is a widespread, socially significant healthcare issue due to the increasing incidence and, particularly, its recurrent nature, despite advances in pharmacotherapy and the application of lithotripsy. Pathological crystal genesis is viewed as a consequence of exceeding the solubility threshold of various urinary mineral components on one hand, and as a result of post-translational defects in the main proteome of urine formation – uromodulin (UMOD), which demonstrates a sanogenetic system in healthy individuals for maintaining biophysical homeostasis stability: the colloidal properties of urine. However, in addition to this, UMOD, by binding mannose-dependent pili of infectious agents, blocks bacterial contact with urothelial cells, given that urinary tract infection is a known factor in urolithiasis. By modeling the urine of healthy individuals through co-incubation with E. coli bacteria, a decrease in the concentration of polymerized uromodulin in urine has been demonstrated as a factor increasing the risk of calcium oxalate crystal formation.
- 14 November 2025
- Published by Federal Budgetary Institution "Research Center for Applied Metrology - Rostest" in Izmeritel`naya Tekhnika
- Vol. 74 (5) , 88-97
Measurements in laboratory medicine and external quality assessment
External quality assessment, conducted in the form of interlaboratory comparisons, is traditionally a tool for verifying laboratory qualifications and confirming the level of measurement accuracy required or claimed by laboratories. The authors identified industry-specific measurement features in laboratory medicine and analyzed long-term participation in the external quality assessment system. Based on these data, the authors concluded that in the absence of appropriate standards, certified reference materials and reference methods for many analytes, the external quality assessment system for medical laboratories acquires a different meaning and becomes an indispensable tool for obtaining objective data on the reproducibility/ consistency of the results obtained in different laboratories, identifying biases in the measurement results of participating laboratories. In such circumstances, an external quality assessment confirms the qualification of a medical laboratory in using a specific analytical technique in combination with reference clinical information corresponding to this particular technique. The results obtained may be of interest to specialists working at the interface of metrology and clinical laboratory diagnostics, as well as manufacturers of medical devices for in vitro diagnostics and external quality assessment providers.
- 14 November 2025
- Published by Federal Budgetary Institution "Research Center for Applied Metrology - Rostest" in Izmeritel`naya Tekhnika
- Vol. 74 (5) , 88-97
Measurements in laboratory medicine and external quality assessment
External quality assessment, conducted in the form of interlaboratory comparisons, is traditionally a tool for verifying laboratory qualifications and confirming the level of measurement accuracy required or claimed by laboratories. The authors identified industry-specific measurement features in laboratory medicine and analyzed long-term participation in the external quality assessment system. Based on these data, the authors concluded that in the absence of appropriate standards, certified reference materials and reference methods for many analytes, the external quality assessment system for medical laboratories acquires a different meaning and becomes an indispensable tool for obtaining objective data on the reproducibility/ consistency of the results obtained in different laboratories, identifying biases in the measurement results of participating laboratories. In such circumstances, an external quality assessment confirms the qualification of a medical laboratory in using a specific analytical technique in combination with reference clinical information corresponding to this particular technique. The results obtained may be of interest to specialists working at the interface of metrology and clinical laboratory diagnostics, as well as manufacturers of medical devices for in vitro diagnostics and external quality assessment providers.
- 1 November 2025
- Published by Springer Nature in Measurement Techniques
- Vol. 68 (9-10) , 612-622
Measurement practices in laboratory medicine and ways to improve external quality assessment
- 1 November 2025
- Published by Springer Nature in Measurement Techniques
- Vol. 68 (9-10) , 612-622
Measurement practices in laboratory medicine and ways to improve external quality assessment